Have vaccine, will travel!

Advertisement

Humans are predictable creatures. Take something away from them that they like then they will get their payback later. In economics, this is called pent-up demand. In the US, where vaccine coverage is fast approaching critical herd immunity levels, the unleashing of pent-up demand has begun in the most singularly crushed sector of any by the pandemic: travel. BofA with the charts:

 Book me a holiday or ten!

Book me a holiday or ten!

Spending is now up year on year but it is still only half what it was in 2019. To say the least, there is a lot of room for explosive catch-up growth here.

In Australia, sadly, our vaccine rollout has been badly mismanaged by the Morrison Government, but it will still progress and we expect the same outcome as vaccines slowly but surely displace lockdowns as the default mechanism for pandemic management.

Advertisement

As such, Aussie travel stocks are headed for a rerating. It has already started but many remain very heavily discounted and deep in value territory:

And yes, we own a good swag of them at home and abroad.

Advertisement
About the author
David Llewellyn-Smith is Chief Strategist at the MB Fund and MB Super. David is the founding publisher and editor of MacroBusiness and was the founding publisher and global economy editor of The Diplomat, the Asia Pacific’s leading geo-politics and economics portal. He is also a former gold trader and economic commentator at The Sydney Morning Herald, The Age, the ABC and Business Spectator. He is the co-author of The Great Crash of 2008 with Ross Garnaut and was the editor of the second Garnaut Climate Change Review.